Peter Scott Chin Insider Profile
4 Followers
Peter Scott Chin, Chief Medical Officer at Denali Therapeutics, holds 204.54K shares in Denali Therapeutics (Ticker: DNLI). Most recently, Peter Scott Chin Sold 1,654 shares of Denali Therapeutics on Sep 09, 2026 for an estimated value of $36.87K.
Peter Scott Chin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Peter Scott Chin's holdings
Insider Roles
Chief Medical Officer
Roles that Peter Scott Chin holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Peter Scott Chin
Peter Scott Chin's Trading History
List of latest transactions for each holding click on a transaction to see Peter Scott Chin's performance on stock
You May Also Like
Peter Scott Chin insider profile FAQ
What is the percentage of profitable transactions made by Peter Scott Chin?
The percentage of profitable transactions made by Peter Scott Chin is ―.
What is the average return per transaction made by Peter Scott Chin?
The average return per transaction made by Peter Scott Chin is ―.
What stocks does Peter Scott Chin hold?
Peter Scott Chin holds: DNLI stocks.
What was Peter Scott Chin’s latest transaction?
Peter Scott Chin latest transaction was an Informative Sell of $36.87K.
What was Peter Scott Chin's most profitable transaction?
Peter Scott Chin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Peter Scott Chin's role in Denali Therapeutics?
Peter Scott Chin's role in Denali Therapeutics is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.